Ian Michael Estepan

Insider Reports History

Location
215 First Street, Ste 415, Cambridge, MA
Signature
/s/ Cristin Rothfuss, as Attorney-in-Fact for Ian Michael Estepan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ian Michael Estepan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sarepta Therapeutics, Inc. Chief Operating Officer Common Stock 206K $4.14M $20.06 Sep 3, 2025 Direct
Sarepta Therapeutics, Inc. Chief Operating Officer Performance Restricted Stock Units 17.5K $2.06M $117.51 Feb 11, 2025 Direct
Sarepta Therapeutics, Inc. Chief Operating Officer Performance Stock Units 6.25K $0 $100.13 Aug 5, 2025 Direct
Sarepta Therapeutics, Inc. Chief Operating Officer Stock Options (right to buy) 16.6K Mar 10, 2025 Direct
Sarepta Therapeutics, Inc. Chief Operating Officer Stock Option (right to buy) 0 Jan 29, 2025 Direct

Insider Reports Filed by Ian Michael Estepan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SRPT Sarepta Therapeutics, Inc. Sep 3, 2025 2 $0 4 Sep 5, 2025 Chief Operating Officer
SRPT Sarepta Therapeutics, Inc. Aug 5, 2025 1 $0 4 Aug 6, 2025 Chief Operating Officer
SRPT Sarepta Therapeutics, Inc. Mar 7, 2025 6 -$395K 4 Mar 11, 2025 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Mar 6, 2025 4 -$1M 4 Mar 10, 2025 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Mar 4, 2025 1 -$139K 4 Mar 6, 2025 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Mar 3, 2025 1 -$57.8K 4 Mar 4, 2025 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Feb 11, 2025 1 $0 4 Feb 13, 2025 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Jan 29, 2025 5 -$117K 4 Jan 31, 2025 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Dec 27, 2024 1 $0 4 Dec 30, 2024 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Aug 30, 2024 1 -$822K 4 Sep 3, 2024 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Jun 21, 2024 5 -$409K 4 Jun 25, 2024 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Mar 7, 2024 2 -$191K 4 Mar 11, 2024 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Mar 4, 2024 1 -$174K 4 Mar 6, 2024 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Mar 1, 2024 4 -$200K 4 Mar 5, 2024 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Mar 8, 2023 1 -$114K 4 Mar 10, 2023 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Mar 6, 2023 3 -$215K 4 Mar 8, 2023 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Mar 1, 2023 1 -$55.8K 4 Mar 3, 2023 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Mar 4, 2022 4 -$135K 4 Mar 8, 2022 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Mar 1, 2022 1 -$28.2K 4 Mar 1, 2022 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Sep 8, 2021 1 -$127K 4 Sep 9, 2021 Chief Financial Officer